Informing patients about the drugs they take

摘要

As increasing numbers of prescription only medicines are released for sale over the counter in pharmacies, consumers would be right to ask questions about the regulation of information about medicines. To date, consumer involvement in the regulatory process has been limited or non-existent, and there are problems across the board in analysing the costs and benefits of over the counter medicines "due to the paucity of data about effectiveness and expenditure in the pharmaceutical sector."